Search

Author/Creator Khan, Nader

1. Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials. Issue 5 (17th February 2020)

Authors:
Poordad, Fred; Castro, RuiSarmento E.; Asatryan, Armen; Aguilar, Humberto; Cacoub, Patrice; Dieterich, Douglas; Marinho, Rui Tato; Carvalho, Armando; Siddique, Asma; Hu, Yiran Bonnie; Charafeddine, Mariem; Bondin, Mark; Khan, Nader; Cohen, Daniel E.; Felizarta, Franco
Journal:
Journal of viral hepatitis
Issue:
Volume 27:Issue 5(2020)
Page Start:
497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search